spacerspacerspacerspacerspacer
Center for BiosecurityUPMC | University of Pittsburgh Medical Center
horizontal rulespacer


Areas of Focus

  
Special Topics
  
Resources
The Center

 

This Website is supported by funding from the Alfred P. Sloan Foundation.
Home > Biosecurity News in Brief > Archive > Government Response > Reports > U.S. House of Representatives Holds Hearing on Biosafety Lab Facilities (10-05-2007)
Tools:||Link to this page| Share this page
horizontal rule
spacer

Biosecurity News in Brief

Subscribe | About | Current Issue | RSS | Archive

U.S. House of Representatives Holds Hearing on Biosafety Lab Facilities

By Molly D’Esopo, October 5, 2007

On October 4, 2007, the U.S. House Subcommittee on Oversight and Investigations held a hearing entitled “Germs, Viruses, and Secrets: The Silent Proliferation of Bio-Laboratories in the United States.” According to a CIDRAP News report, the hearing “was the first of a series of committee hearings” which will address biosecurity and biosafety issues including “biosafety at labs outside of the United States and the proposed closure of the BSL 4 facility at Plum Island, N.Y.”1

At issue is the lack of federal oversight of or even basic knowledge about BSL-3 and BSL-4 laboratory facilities, where research is conducted on some of the most dangerous pathogens. MarketWatch reported that information is available on laboratories receiving federal research dollars and those that conduct research on the select agents; but there is a void of knowledge regarding countless other labs and according to a new GAO report, “no agency is responsible for determining the risks associated with the proliferation of the labs.” Rep. Bart Stupak (D-MI), who led the hearing, noted that "No one in the federal government even knows for sure how many of these labs there are in the U.S., much less what research they are doing, or whether they are safe and secure."2

Dr. Richard Besser, director of CDC’s Coordinating Office for Terrorism Preparedness and Emergency Response, testified that CDC is looking to improve its lab inspection program and to increase the frequency with which inspections are conducted. Ed Davis, interim president of Texas A&M, an institution which failed to report lab accidents last year, suggested that greater federal involvement could lead to greater biosafety compliance within labs. "We should have a program that can endure any type of inspection, announced or unannounced," he noted.3 In his testimony, Ed Hammond, director of The Sunshine Project, a watchdog group that exposed the Texas A&M lab accidents, also advocated for greater transparency: "There's a positive correlation between transparency and compliance and reporting."1

Dr. Gigi Kwik Gronvall, Senior Associate at the Center for Biosecurity of UPMC, noted in her testimony the findings of a group experts convened in March to examine lab safety and security issues as well as the relationships between laboratories and communities in which they are located. Specifically, Dr. Gronvall recommended:

  • “expanding biosafety training for researchers and workers coming into high-containment research from less dangerous areas of research;”
  • “monitoring the safety performance and operational experience of the high-containment facilities;”
  • “increasing communication between the high-containment laboratories to share operational experiences; and”
  • “initiating a public engagement effort at the federal level that clarifies the need for high-containment laboratories.”4

References

  1. Schnirring L. House committee airs safety concerns about biodefense labs. CIDRAP News. October 4, 2007. http://www.cidrap.umn.edu/cidrap/content/bt/bioprep/news/oct0407hearing.html. Accessed October 5, 2007.
  2. Mantell R. Growth of biosafety labs poses unknown risks: GAO report says no one agency tracks potentially dangerous facilities. MarketWatch. October 5, 2007. http://www.marketwatch.com/news/story/growth-biosafety-labs-not-fully/story.aspx?guid=%7B17C09EC5-F180-42F7-865C-B5CA005A8873%7D. Accessed October 5, 2007.
  3. Margasak L. CDC to review inspections rules for labs. The Associated Press. October 4, 2007. http://hosted.ap.org/dynamic/stories/D/DANGEROUS_GERMS?SITE=ORMED&SECTION=HOME&TEMPLATE=DEFAULT. Accessed October 5, 2007.
  4. Gronvall G. Testimony of Gigi Kwik Gronvall, Ph.D., Senior Associate, Center for Biosecurity of UPMC before the U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations. http://www.upmc-biosecurity.org/website/resources/hearings/content/Hearings_2007/20071004-germsvirusesandsecrets.html. Accessed October 4, 2007.